John Menditto | VP, Investor Relations & Corporate Communications |
David Mazzo | President & Chief Executive Officer |
James Nisco | Vice President of Finance & Treasury |
Kristen Buck | Chief Medical Officer |
Kumar Raja | Brookline Capital Markets |
Pete Enderlin | MAZ Partners |
Welcome to the Caladrius Biosciences First Quarter 2022 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this call is being recorded today, Thursday, May 5, 2022. I will now turn the call over to John Menditto, Vice President of Investor Relations and Corporate Communications at Koletreus. Please go ahead.